Sandoz entitled to generic Lexapro licence, IP Australia finds in blow to Lundbeck
Clayton Utz 2019-04-15 10:18 pm By Christine Caulfield | Melbourne
Please login to bookmark Close

Generic drug maker Sandoz has secured a retroactive licence to manufacture a cheaper version of top-selling antidepressant Lexapro, the drug at the heart of a long-running patent infringement battle with pharmaceutical giant Lundbeck.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au